BAmyloid Peptide/a2 Macroglobulin Interactions

Steven Gonias, MD, PhD
University of Virginia (Charlottesville, VA)
Year Awarded:
2001
Grant Duration:
April 1, 2001 to March 31, 2003
Disease:
Alzheimer's Disease
Award Amount:
$199,947
Grant Reference ID:
A2001011
Award Type:
Standard
Award Region:
US Southeastern

BAmyloid Peptide/a2 Macroglobulin Interactions

Details


Recent studies suggest that if the clearance of amyloid beta from the extracellular spaces of the brain is enhanced (through a vaccine), the progression of Alzheimer's disease (AD) may be stopped or reversed. A protein called a2-Macroglobulin (a2M) is a naturally occurring protein present in human blood and in the spaces between cells. This large protein contains a number of distinct binding sites for other, smaller proteins, including a binding site for growth factors near the center of the a2M structure. By binding growth factors, a2M may harm cells and increase cell death when excessive amyloid beta is present. Dr. Gonias has evidence suggesting that there is a distinct region in the structure of a2M that binds Alpha-beta. His goal is to further define the Alpha-beta binding site in a2M, with the long-range goal of identifying a2M miniproteins to mediate Alpha-beta catabolism and counteract the toxic activity of Alpha-beta. This study is a continuation of a project launched in 1999.

Publications

Mettenberg, J.M., Webb, D.J., and Gonias, S.L. (2002) Distinct binding sites in the structure of alpha-2-macroglobulin mediate the interation with beta-amyloid peptide and growth factors. J. Biol. Chem. 277(15):13338-13345.  

Don't miss out.
Receive research updates, inspiring stories, and expert advice
Please enter your first name.
Please enter your last name.
Keep me informed about: *
Please select at least one.
You must select at least one disease category.